SMMT

Summit Therapeutics Inc

May 20 • 04:00PM ET

17.89

+2.04 12.87 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: INCY KYMR EXEL LEGN ARGX SRPT HALO BMRN KRYS UTHR

| Held by: XBI VTI VB VXF VBR IBB IWP VHT IWF IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.60	Insider Own	82.66%	Shs Outstand	776.02M	Perf Week	-4.79%
Market Cap	13.87B	Forward P/E	-	EPS next Y	-1.16	Insider Trans	0.00%	Shs Float	134.46M	Perf Month	-32.18%
Enterprise Value	13.29B	PEG	-	EPS next Q	-0.28	Inst Own	15.54%	Short Float	21.71%	Perf Quarter	12.73%
Income	-1.21B	P/S	-	EPS this Y	20.73%	Inst Trans	11.35%	Short Ratio	8.57	Perf Half Y	5.55%
Sales	0.00M	P/B	25.43	EPS next Y	-1.75%	ROA	-233.81%	Short Interest	29.19M	Perf YTD	2.29%
Book/sh	0.70	P/C	23.16	EPS next 5Y	28.68%	ROE	-270.95%	52W High	30.98 -42.25%	Perf Year	-26.65%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	-52.45% -13.76%	ROIC	-214.31%	52W Low	13.83 29.36%	Perf 3Y	964.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.12% 7.09%	Perf 5Y	137.58%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-384.68%	Oper. Margin	-	ATR (14)	1.43	Perf 10Y	116.24%
Dividend Ex-Date	-	Quick Ratio	7.41	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.81	Recom	1.71
Dividend Gr. 3/5Y	- -	Current Ratio	7.41	EPS Q/Q	-186.74%	SMA20	-4.56%	Beta	-1.28	Target Price	30.00
Payout	-	Debt/Eq	0.04	Sales Q/Q	-	SMA50	-5.04%	Rel Volume	1.36	Prev Close	15.85
Employees	265	LT Debt/Eq	0.03	Earnings	Apr 30 AMC	SMA200	-6.26%	Avg Volume	3.41M	Price	17.89
IPO	Mar 05, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.85% -100.00%	Trades		Volume	4,624,247	Change	12.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)